Cambridge, UK-based Neurocrine Biosciences - partnered with Japan’s Nxera Pharma - has announced it has received IND ...

Europe. Whilst long recognised as Europe's largest partnering conference, it's now expanding to become the continent's most ...

The US FDA announced two De Novo marketing authorisations for novel medical devices this week: A continuous glucose monitor ...

AI has kickstarted a new wave of innovation in biopharma R&D, reshaping how organisations approach some of the most complex ...

Public demand for prevention is surging, with 33.6 million people now using the NHS App, yet, NHS leaders say the digital ...

A year after officially launching its AI agency offering, EVERSANA is expanding the platform’s capabilities and announcing a ...

Roche has won US FDA clearance for a blood test that could move Alzheimer’s biomarker testing further into primary care, ...

Johnson & Johnson has announced that the US Food and Drug Administration (FDA) has approved Imaavy (nipocalimab-aahu) for the ...

CHB is a major public health challenge and a leading cause of liver cancer globally. Chronic hepatitis B occurs when the ...

Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity ...

The European Commission has granted marketing authorisation to Gilead for Trodelvy (sacituzumab govitecan-hziy) in ...

As clinical trials become more complex, sponsors face growing pressure to reach more representative patient populations while ...